BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kaplan N, Kabatas S, Civelek E, Savrunlu EC, Akkoc T, Boyalı O, Öztürk E, Can H, Genc A, Karaöz E. Multiroute administration of Wharton’s jelly mesenchymal stem cells in chronic complete spinal cord injury: A phase I safety and feasibility study. World J Stem Cells 2025; 17(5): 101675 [PMID: 40503363 DOI: 10.4252/wjsc.v17.i5.101675]
URL: https://www.wjgnet.com/1948-0210/full/v17/i5/101675.htm
Number Citing Articles
1
Jing Zhang, Yunqi Li, Penghui Ren, Mengna Jiang, Ping Wu, Qingping Wen. Efficacy and safety of intrathecal human umbilical cord-derived mesenchymal stromal cell therapy for bone cancer pain: a preclinical studyStem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04820-6
2
Tomasz Górnicki, Małgorzata Józkowiak, Krzysztof Data, Dominika Domagała, Julia Niebora, Ewa Okowińska, Anna Kłopot, Magdalena Kulus, Artur Bryja, Sławomir Woźniak, Adam Kamiński, Piotr Chmielewski, Aleksandra Górska, Aleksandra Partyńska, Teresa Wysocka, Marek Spaczyński, Hanna Piotrowska-Kempisty, Piotr Dzięgiel, Paul Mozdziak, Bogusław Czerny, Bartosz Kempisty. Wharton’s jelly mesenchymal stem cells (WJ-MSCs), a “Holy Grail” in tissue bioengineering and reconstructive medicineBiomedicine & Pharmacotherapy 2025; 192: 118570 doi: 10.1016/j.biopha.2025.118570
3
Matthew Shkap, Daria Namestnikova, Elvira Cherkashova, Daria Chudakova, Arthur Biktimirov, Konstantin Yarygin, Vladimir Baklaushev. Clinical Insights into Mesenchymal Stem Cell Applications for Spinal Cord InjuryInternational Journal of Molecular Sciences 2025; 26(24): 12139 doi: 10.3390/ijms262412139
4
Mi Zhou, Xue Yao, Boya Huang, Jie Ren, Haiwen Feng, Shiqing Feng. Frontier Integration in Spinal Cord Injury Repair: Engineering-Driven Mechanistic Exploration and a New Paradigm for Clinical TranslationEngineering 2025;  doi: 10.1016/j.eng.2025.11.012